Question 1

What is the catalog number for O-1602?

Accepted Answer

The catalog number for O-1602 is M33897.

Question 2

What sizes are available for O-1602?

Accepted Answer

O-1602 is available in the following size(s): 1 g, 500 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg.

Question 3

How many pack sizes does O-1602 come in?

Accepted Answer

O-1602 is available in 8 different pack sizes.

Question 4

Is O-1602 in stock?

Accepted Answer

O-1602 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is O-1602 used for?

Accepted Answer

O-1602 is a novel GPR55 agonist, an atypical cannabinoid associated with the central nervous system and obesity, and is a candidate compound for the treatment of cystitis.O-1602 promotes hepatic steatosis through GPR55 and PI3 kinase / Akt / SREBP-1c signalling in mice.O-1602 induces, in a GPR3-inde

Question 6

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 7

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

Question 8

What is the recommended positive control for this assay?

Accepted Answer

A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.

O-1602

Product Specifications

CAS Number

Stability

Purity

Weight

Molecular Formula

Notes

Receptor

Available Sizes

Frequently Asked Questions

Explore Other Products

TCP1 Antibody, FITC conjugated

TCP1 Antibody, FITC conjugated

Lentiviral mouse Gm5796 shRNA (UAS) - Lentiviral mouse Gm5796 shRNA (UAS, iRFP) plasmid

Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb - Research Grade

Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb - Research Grade

Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb - Research Grade